Medical Care
Global Leukemia Cancer Market Research Report 2025
- Sep 06, 25
- ID: 492859
- Pages: 84
- Figures: 84
- Views: 7
This report aims to provide a comprehensive presentation of the global market for Leukemia Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukemia Cancer.
The Leukemia Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Leukemia Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Leukemia Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biogen
GSK
Novartis
Pfizer
Roche
Takeda Oncology
Teva Pharmaceutical
Celgene
Daiichi Sankyo
EISAI
Sunesis Pharmaceuticals
Bristol-Myers Squibb
Spectrum Pharmaceuticals
Segment by Type
Chemotherapy
Radiation Therapy
Targeted Therapy
Biological Therapy
Stem Cell Transplant
Segment by Application
Acute Myeloid Leukaemia (AML)
Chronic Myeloid Leukaemia (CML)
Acute Lymphoblastic Leukaemia (ALL)
Chronic Lymphocytic Leukaemia (CLL)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leukemia Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Leukemia Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Leukemia Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Leukemia Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biogen
GSK
Novartis
Pfizer
Roche
Takeda Oncology
Teva Pharmaceutical
Celgene
Daiichi Sankyo
EISAI
Sunesis Pharmaceuticals
Bristol-Myers Squibb
Spectrum Pharmaceuticals
Segment by Type
Chemotherapy
Radiation Therapy
Targeted Therapy
Biological Therapy
Stem Cell Transplant
Segment by Application
Acute Myeloid Leukaemia (AML)
Chronic Myeloid Leukaemia (CML)
Acute Lymphoblastic Leukaemia (ALL)
Chronic Lymphocytic Leukaemia (CLL)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leukemia Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Targeted Therapy
1.2.5 Biological Therapy
1.2.6 Stem Cell Transplant
1.3 Market by Application
1.3.1 Global Leukemia Cancer Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Acute Myeloid Leukaemia (AML)
1.3.3 Chronic Myeloid Leukaemia (CML)
1.3.4 Acute Lymphoblastic Leukaemia (ALL)
1.3.5 Chronic Lymphocytic Leukaemia (CLL)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leukemia Cancer Market Perspective (2020-2031)
2.2 Global Leukemia Cancer Growth Trends by Region
2.2.1 Global Leukemia Cancer Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Leukemia Cancer Historic Market Size by Region (2020-2025)
2.2.3 Leukemia Cancer Forecasted Market Size by Region (2026-2031)
2.3 Leukemia Cancer Market Dynamics
2.3.1 Leukemia Cancer Industry Trends
2.3.2 Leukemia Cancer Market Drivers
2.3.3 Leukemia Cancer Market Challenges
2.3.4 Leukemia Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukemia Cancer Players by Revenue
3.1.1 Global Top Leukemia Cancer Players by Revenue (2020-2025)
3.1.2 Global Leukemia Cancer Revenue Market Share by Players (2020-2025)
3.2 Global Leukemia Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Leukemia Cancer Revenue
3.4 Global Leukemia Cancer Market Concentration Ratio
3.4.1 Global Leukemia Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Cancer Revenue in 2024
3.5 Global Key Players of Leukemia Cancer Head office and Area Served
3.6 Global Key Players of Leukemia Cancer, Product and Application
3.7 Global Key Players of Leukemia Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Leukemia Cancer Breakdown Data by Type
4.1 Global Leukemia Cancer Historic Market Size by Type (2020-2025)
4.2 Global Leukemia Cancer Forecasted Market Size by Type (2026-2031)
5 Leukemia Cancer Breakdown Data by Application
5.1 Global Leukemia Cancer Historic Market Size by Application (2020-2025)
5.2 Global Leukemia Cancer Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Leukemia Cancer Market Size (2020-2031)
6.2 North America Leukemia Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Leukemia Cancer Market Size by Country (2020-2025)
6.4 North America Leukemia Cancer Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Leukemia Cancer Market Size (2020-2031)
7.2 Europe Leukemia Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Leukemia Cancer Market Size by Country (2020-2025)
7.4 Europe Leukemia Cancer Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Leukemia Cancer Market Size (2020-2031)
8.2 Asia-Pacific Leukemia Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Leukemia Cancer Market Size by Region (2020-2025)
8.4 Asia-Pacific Leukemia Cancer Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Leukemia Cancer Market Size (2020-2031)
9.2 Latin America Leukemia Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Leukemia Cancer Market Size by Country (2020-2025)
9.4 Latin America Leukemia Cancer Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukemia Cancer Market Size (2020-2031)
10.2 Middle East & Africa Leukemia Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Leukemia Cancer Market Size by Country (2020-2025)
10.4 Middle East & Africa Leukemia Cancer Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Leukemia Cancer Introduction
11.1.4 Biogen Revenue in Leukemia Cancer Business (2020-2025)
11.1.5 Biogen Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Leukemia Cancer Introduction
11.2.4 GSK Revenue in Leukemia Cancer Business (2020-2025)
11.2.5 GSK Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Leukemia Cancer Introduction
11.3.4 Novartis Revenue in Leukemia Cancer Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Leukemia Cancer Introduction
11.4.4 Pfizer Revenue in Leukemia Cancer Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Leukemia Cancer Introduction
11.5.4 Roche Revenue in Leukemia Cancer Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Takeda Oncology
11.6.1 Takeda Oncology Company Details
11.6.2 Takeda Oncology Business Overview
11.6.3 Takeda Oncology Leukemia Cancer Introduction
11.6.4 Takeda Oncology Revenue in Leukemia Cancer Business (2020-2025)
11.6.5 Takeda Oncology Recent Development
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Leukemia Cancer Introduction
11.7.4 Teva Pharmaceutical Revenue in Leukemia Cancer Business (2020-2025)
11.7.5 Teva Pharmaceutical Recent Development
11.8 Celgene
11.8.1 Celgene Company Details
11.8.2 Celgene Business Overview
11.8.3 Celgene Leukemia Cancer Introduction
11.8.4 Celgene Revenue in Leukemia Cancer Business (2020-2025)
11.8.5 Celgene Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Leukemia Cancer Introduction
11.9.4 Daiichi Sankyo Revenue in Leukemia Cancer Business (2020-2025)
11.9.5 Daiichi Sankyo Recent Development
11.10 EISAI
11.10.1 EISAI Company Details
11.10.2 EISAI Business Overview
11.10.3 EISAI Leukemia Cancer Introduction
11.10.4 EISAI Revenue in Leukemia Cancer Business (2020-2025)
11.10.5 EISAI Recent Development
11.11 Sunesis Pharmaceuticals
11.11.1 Sunesis Pharmaceuticals Company Details
11.11.2 Sunesis Pharmaceuticals Business Overview
11.11.3 Sunesis Pharmaceuticals Leukemia Cancer Introduction
11.11.4 Sunesis Pharmaceuticals Revenue in Leukemia Cancer Business (2020-2025)
11.11.5 Sunesis Pharmaceuticals Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Leukemia Cancer Introduction
11.12.4 Bristol-Myers Squibb Revenue in Leukemia Cancer Business (2020-2025)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Spectrum Pharmaceuticals
11.13.1 Spectrum Pharmaceuticals Company Details
11.13.2 Spectrum Pharmaceuticals Business Overview
11.13.3 Spectrum Pharmaceuticals Leukemia Cancer Introduction
11.13.4 Spectrum Pharmaceuticals Revenue in Leukemia Cancer Business (2020-2025)
11.13.5 Spectrum Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Targeted Therapy
1.2.5 Biological Therapy
1.2.6 Stem Cell Transplant
1.3 Market by Application
1.3.1 Global Leukemia Cancer Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Acute Myeloid Leukaemia (AML)
1.3.3 Chronic Myeloid Leukaemia (CML)
1.3.4 Acute Lymphoblastic Leukaemia (ALL)
1.3.5 Chronic Lymphocytic Leukaemia (CLL)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leukemia Cancer Market Perspective (2020-2031)
2.2 Global Leukemia Cancer Growth Trends by Region
2.2.1 Global Leukemia Cancer Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Leukemia Cancer Historic Market Size by Region (2020-2025)
2.2.3 Leukemia Cancer Forecasted Market Size by Region (2026-2031)
2.3 Leukemia Cancer Market Dynamics
2.3.1 Leukemia Cancer Industry Trends
2.3.2 Leukemia Cancer Market Drivers
2.3.3 Leukemia Cancer Market Challenges
2.3.4 Leukemia Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukemia Cancer Players by Revenue
3.1.1 Global Top Leukemia Cancer Players by Revenue (2020-2025)
3.1.2 Global Leukemia Cancer Revenue Market Share by Players (2020-2025)
3.2 Global Leukemia Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Leukemia Cancer Revenue
3.4 Global Leukemia Cancer Market Concentration Ratio
3.4.1 Global Leukemia Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Cancer Revenue in 2024
3.5 Global Key Players of Leukemia Cancer Head office and Area Served
3.6 Global Key Players of Leukemia Cancer, Product and Application
3.7 Global Key Players of Leukemia Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Leukemia Cancer Breakdown Data by Type
4.1 Global Leukemia Cancer Historic Market Size by Type (2020-2025)
4.2 Global Leukemia Cancer Forecasted Market Size by Type (2026-2031)
5 Leukemia Cancer Breakdown Data by Application
5.1 Global Leukemia Cancer Historic Market Size by Application (2020-2025)
5.2 Global Leukemia Cancer Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Leukemia Cancer Market Size (2020-2031)
6.2 North America Leukemia Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Leukemia Cancer Market Size by Country (2020-2025)
6.4 North America Leukemia Cancer Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Leukemia Cancer Market Size (2020-2031)
7.2 Europe Leukemia Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Leukemia Cancer Market Size by Country (2020-2025)
7.4 Europe Leukemia Cancer Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Leukemia Cancer Market Size (2020-2031)
8.2 Asia-Pacific Leukemia Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Leukemia Cancer Market Size by Region (2020-2025)
8.4 Asia-Pacific Leukemia Cancer Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Leukemia Cancer Market Size (2020-2031)
9.2 Latin America Leukemia Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Leukemia Cancer Market Size by Country (2020-2025)
9.4 Latin America Leukemia Cancer Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukemia Cancer Market Size (2020-2031)
10.2 Middle East & Africa Leukemia Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Leukemia Cancer Market Size by Country (2020-2025)
10.4 Middle East & Africa Leukemia Cancer Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Leukemia Cancer Introduction
11.1.4 Biogen Revenue in Leukemia Cancer Business (2020-2025)
11.1.5 Biogen Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Leukemia Cancer Introduction
11.2.4 GSK Revenue in Leukemia Cancer Business (2020-2025)
11.2.5 GSK Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Leukemia Cancer Introduction
11.3.4 Novartis Revenue in Leukemia Cancer Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Leukemia Cancer Introduction
11.4.4 Pfizer Revenue in Leukemia Cancer Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Leukemia Cancer Introduction
11.5.4 Roche Revenue in Leukemia Cancer Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Takeda Oncology
11.6.1 Takeda Oncology Company Details
11.6.2 Takeda Oncology Business Overview
11.6.3 Takeda Oncology Leukemia Cancer Introduction
11.6.4 Takeda Oncology Revenue in Leukemia Cancer Business (2020-2025)
11.6.5 Takeda Oncology Recent Development
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Leukemia Cancer Introduction
11.7.4 Teva Pharmaceutical Revenue in Leukemia Cancer Business (2020-2025)
11.7.5 Teva Pharmaceutical Recent Development
11.8 Celgene
11.8.1 Celgene Company Details
11.8.2 Celgene Business Overview
11.8.3 Celgene Leukemia Cancer Introduction
11.8.4 Celgene Revenue in Leukemia Cancer Business (2020-2025)
11.8.5 Celgene Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Leukemia Cancer Introduction
11.9.4 Daiichi Sankyo Revenue in Leukemia Cancer Business (2020-2025)
11.9.5 Daiichi Sankyo Recent Development
11.10 EISAI
11.10.1 EISAI Company Details
11.10.2 EISAI Business Overview
11.10.3 EISAI Leukemia Cancer Introduction
11.10.4 EISAI Revenue in Leukemia Cancer Business (2020-2025)
11.10.5 EISAI Recent Development
11.11 Sunesis Pharmaceuticals
11.11.1 Sunesis Pharmaceuticals Company Details
11.11.2 Sunesis Pharmaceuticals Business Overview
11.11.3 Sunesis Pharmaceuticals Leukemia Cancer Introduction
11.11.4 Sunesis Pharmaceuticals Revenue in Leukemia Cancer Business (2020-2025)
11.11.5 Sunesis Pharmaceuticals Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Leukemia Cancer Introduction
11.12.4 Bristol-Myers Squibb Revenue in Leukemia Cancer Business (2020-2025)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Spectrum Pharmaceuticals
11.13.1 Spectrum Pharmaceuticals Company Details
11.13.2 Spectrum Pharmaceuticals Business Overview
11.13.3 Spectrum Pharmaceuticals Leukemia Cancer Introduction
11.13.4 Spectrum Pharmaceuticals Revenue in Leukemia Cancer Business (2020-2025)
11.13.5 Spectrum Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Leukemia Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Biological Therapy
Table 6. Key Players of Stem Cell Transplant
Table 7. Global Leukemia Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Leukemia Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Leukemia Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Leukemia Cancer Market Share by Region (2020-2025)
Table 11. Global Leukemia Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Leukemia Cancer Market Share by Region (2026-2031)
Table 13. Leukemia Cancer Market Trends
Table 14. Leukemia Cancer Market Drivers
Table 15. Leukemia Cancer Market Challenges
Table 16. Leukemia Cancer Market Restraints
Table 17. Global Leukemia Cancer Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Leukemia Cancer Market Share by Players (2020-2025)
Table 19. Global Top Leukemia Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Cancer as of 2024)
Table 20. Ranking of Global Top Leukemia Cancer Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Leukemia Cancer Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Leukemia Cancer, Headquarters and Area Served
Table 23. Global Key Players of Leukemia Cancer, Product and Application
Table 24. Global Key Players of Leukemia Cancer, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Leukemia Cancer Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Leukemia Cancer Revenue Market Share by Type (2020-2025)
Table 28. Global Leukemia Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Leukemia Cancer Revenue Market Share by Type (2026-2031)
Table 30. Global Leukemia Cancer Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Leukemia Cancer Revenue Market Share by Application (2020-2025)
Table 32. Global Leukemia Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Leukemia Cancer Revenue Market Share by Application (2026-2031)
Table 34. North America Leukemia Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Leukemia Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Leukemia Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Leukemia Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Leukemia Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Leukemia Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Leukemia Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Leukemia Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Leukemia Cancer Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Leukemia Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Leukemia Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Leukemia Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Leukemia Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Leukemia Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Leukemia Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 49. Biogen Company Details
Table 50. Biogen Business Overview
Table 51. Biogen Leukemia Cancer Product
Table 52. Biogen Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 53. Biogen Recent Development
Table 54. GSK Company Details
Table 55. GSK Business Overview
Table 56. GSK Leukemia Cancer Product
Table 57. GSK Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 58. GSK Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis Leukemia Cancer Product
Table 62. Novartis Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Leukemia Cancer Product
Table 67. Pfizer Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche Leukemia Cancer Product
Table 72. Roche Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 73. Roche Recent Development
Table 74. Takeda Oncology Company Details
Table 75. Takeda Oncology Business Overview
Table 76. Takeda Oncology Leukemia Cancer Product
Table 77. Takeda Oncology Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 78. Takeda Oncology Recent Development
Table 79. Teva Pharmaceutical Company Details
Table 80. Teva Pharmaceutical Business Overview
Table 81. Teva Pharmaceutical Leukemia Cancer Product
Table 82. Teva Pharmaceutical Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 83. Teva Pharmaceutical Recent Development
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Leukemia Cancer Product
Table 87. Celgene Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 88. Celgene Recent Development
Table 89. Daiichi Sankyo Company Details
Table 90. Daiichi Sankyo Business Overview
Table 91. Daiichi Sankyo Leukemia Cancer Product
Table 92. Daiichi Sankyo Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 93. Daiichi Sankyo Recent Development
Table 94. EISAI Company Details
Table 95. EISAI Business Overview
Table 96. EISAI Leukemia Cancer Product
Table 97. EISAI Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 98. EISAI Recent Development
Table 99. Sunesis Pharmaceuticals Company Details
Table 100. Sunesis Pharmaceuticals Business Overview
Table 101. Sunesis Pharmaceuticals Leukemia Cancer Product
Table 102. Sunesis Pharmaceuticals Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 103. Sunesis Pharmaceuticals Recent Development
Table 104. Bristol-Myers Squibb Company Details
Table 105. Bristol-Myers Squibb Business Overview
Table 106. Bristol-Myers Squibb Leukemia Cancer Product
Table 107. Bristol-Myers Squibb Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 108. Bristol-Myers Squibb Recent Development
Table 109. Spectrum Pharmaceuticals Company Details
Table 110. Spectrum Pharmaceuticals Business Overview
Table 111. Spectrum Pharmaceuticals Leukemia Cancer Product
Table 112. Spectrum Pharmaceuticals Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 113. Spectrum Pharmaceuticals Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 117. Authors List of This Report
List of Figures
Figure 1. Leukemia Cancer Picture
Figure 2. Global Leukemia Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Leukemia Cancer Market Share by Type: 2024 VS 2031
Figure 4. Chemotherapy Features
Figure 5. Radiation Therapy Features
Figure 6. Targeted Therapy Features
Figure 7. Biological Therapy Features
Figure 8. Stem Cell Transplant Features
Figure 9. Global Leukemia Cancer Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Leukemia Cancer Market Share by Application: 2024 VS 2031
Figure 11. Acute Myeloid Leukaemia (AML) Case Studies
Figure 12. Chronic Myeloid Leukaemia (CML) Case Studies
Figure 13. Acute Lymphoblastic Leukaemia (ALL) Case Studies
Figure 14. Chronic Lymphocytic Leukaemia (CLL) Case Studies
Figure 15. Leukemia Cancer Report Years Considered
Figure 16. Global Leukemia Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Leukemia Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Leukemia Cancer Market Share by Region: 2024 VS 2031
Figure 19. Global Leukemia Cancer Market Share by Players in 2024
Figure 20. Global Top Leukemia Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Cancer as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Leukemia Cancer Revenue in 2024
Figure 22. North America Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Leukemia Cancer Market Share by Country (2020-2031)
Figure 24. United States Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Leukemia Cancer Market Share by Country (2020-2031)
Figure 28. Germany Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Leukemia Cancer Market Share by Region (2020-2031)
Figure 36. China Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Leukemia Cancer Market Share by Country (2020-2031)
Figure 44. Mexico Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Leukemia Cancer Market Share by Country (2020-2031)
Figure 48. Turkey Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Biogen Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 52. GSK Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 54. Pfizer Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 55. Roche Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 56. Takeda Oncology Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 57. Teva Pharmaceutical Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 58. Celgene Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 59. Daiichi Sankyo Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 60. EISAI Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 61. Sunesis Pharmaceuticals Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 63. Spectrum Pharmaceuticals Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Leukemia Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Biological Therapy
Table 6. Key Players of Stem Cell Transplant
Table 7. Global Leukemia Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Leukemia Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Leukemia Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Leukemia Cancer Market Share by Region (2020-2025)
Table 11. Global Leukemia Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Leukemia Cancer Market Share by Region (2026-2031)
Table 13. Leukemia Cancer Market Trends
Table 14. Leukemia Cancer Market Drivers
Table 15. Leukemia Cancer Market Challenges
Table 16. Leukemia Cancer Market Restraints
Table 17. Global Leukemia Cancer Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Leukemia Cancer Market Share by Players (2020-2025)
Table 19. Global Top Leukemia Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Cancer as of 2024)
Table 20. Ranking of Global Top Leukemia Cancer Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Leukemia Cancer Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Leukemia Cancer, Headquarters and Area Served
Table 23. Global Key Players of Leukemia Cancer, Product and Application
Table 24. Global Key Players of Leukemia Cancer, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Leukemia Cancer Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Leukemia Cancer Revenue Market Share by Type (2020-2025)
Table 28. Global Leukemia Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Leukemia Cancer Revenue Market Share by Type (2026-2031)
Table 30. Global Leukemia Cancer Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Leukemia Cancer Revenue Market Share by Application (2020-2025)
Table 32. Global Leukemia Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Leukemia Cancer Revenue Market Share by Application (2026-2031)
Table 34. North America Leukemia Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Leukemia Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Leukemia Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Leukemia Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Leukemia Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Leukemia Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Leukemia Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Leukemia Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Leukemia Cancer Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Leukemia Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Leukemia Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Leukemia Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Leukemia Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Leukemia Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Leukemia Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 49. Biogen Company Details
Table 50. Biogen Business Overview
Table 51. Biogen Leukemia Cancer Product
Table 52. Biogen Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 53. Biogen Recent Development
Table 54. GSK Company Details
Table 55. GSK Business Overview
Table 56. GSK Leukemia Cancer Product
Table 57. GSK Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 58. GSK Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis Leukemia Cancer Product
Table 62. Novartis Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Leukemia Cancer Product
Table 67. Pfizer Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche Leukemia Cancer Product
Table 72. Roche Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 73. Roche Recent Development
Table 74. Takeda Oncology Company Details
Table 75. Takeda Oncology Business Overview
Table 76. Takeda Oncology Leukemia Cancer Product
Table 77. Takeda Oncology Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 78. Takeda Oncology Recent Development
Table 79. Teva Pharmaceutical Company Details
Table 80. Teva Pharmaceutical Business Overview
Table 81. Teva Pharmaceutical Leukemia Cancer Product
Table 82. Teva Pharmaceutical Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 83. Teva Pharmaceutical Recent Development
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Leukemia Cancer Product
Table 87. Celgene Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 88. Celgene Recent Development
Table 89. Daiichi Sankyo Company Details
Table 90. Daiichi Sankyo Business Overview
Table 91. Daiichi Sankyo Leukemia Cancer Product
Table 92. Daiichi Sankyo Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 93. Daiichi Sankyo Recent Development
Table 94. EISAI Company Details
Table 95. EISAI Business Overview
Table 96. EISAI Leukemia Cancer Product
Table 97. EISAI Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 98. EISAI Recent Development
Table 99. Sunesis Pharmaceuticals Company Details
Table 100. Sunesis Pharmaceuticals Business Overview
Table 101. Sunesis Pharmaceuticals Leukemia Cancer Product
Table 102. Sunesis Pharmaceuticals Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 103. Sunesis Pharmaceuticals Recent Development
Table 104. Bristol-Myers Squibb Company Details
Table 105. Bristol-Myers Squibb Business Overview
Table 106. Bristol-Myers Squibb Leukemia Cancer Product
Table 107. Bristol-Myers Squibb Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 108. Bristol-Myers Squibb Recent Development
Table 109. Spectrum Pharmaceuticals Company Details
Table 110. Spectrum Pharmaceuticals Business Overview
Table 111. Spectrum Pharmaceuticals Leukemia Cancer Product
Table 112. Spectrum Pharmaceuticals Revenue in Leukemia Cancer Business (2020-2025) & (US$ Million)
Table 113. Spectrum Pharmaceuticals Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 117. Authors List of This Report
List of Figures
Figure 1. Leukemia Cancer Picture
Figure 2. Global Leukemia Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Leukemia Cancer Market Share by Type: 2024 VS 2031
Figure 4. Chemotherapy Features
Figure 5. Radiation Therapy Features
Figure 6. Targeted Therapy Features
Figure 7. Biological Therapy Features
Figure 8. Stem Cell Transplant Features
Figure 9. Global Leukemia Cancer Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Leukemia Cancer Market Share by Application: 2024 VS 2031
Figure 11. Acute Myeloid Leukaemia (AML) Case Studies
Figure 12. Chronic Myeloid Leukaemia (CML) Case Studies
Figure 13. Acute Lymphoblastic Leukaemia (ALL) Case Studies
Figure 14. Chronic Lymphocytic Leukaemia (CLL) Case Studies
Figure 15. Leukemia Cancer Report Years Considered
Figure 16. Global Leukemia Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Leukemia Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Leukemia Cancer Market Share by Region: 2024 VS 2031
Figure 19. Global Leukemia Cancer Market Share by Players in 2024
Figure 20. Global Top Leukemia Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Cancer as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Leukemia Cancer Revenue in 2024
Figure 22. North America Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Leukemia Cancer Market Share by Country (2020-2031)
Figure 24. United States Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Leukemia Cancer Market Share by Country (2020-2031)
Figure 28. Germany Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Leukemia Cancer Market Share by Region (2020-2031)
Figure 36. China Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Leukemia Cancer Market Share by Country (2020-2031)
Figure 44. Mexico Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Leukemia Cancer Market Share by Country (2020-2031)
Figure 48. Turkey Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Leukemia Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Biogen Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 52. GSK Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 54. Pfizer Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 55. Roche Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 56. Takeda Oncology Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 57. Teva Pharmaceutical Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 58. Celgene Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 59. Daiichi Sankyo Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 60. EISAI Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 61. Sunesis Pharmaceuticals Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 63. Spectrum Pharmaceuticals Revenue Growth Rate in Leukemia Cancer Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232